DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
Dissecting pOXA-48 fitness effects in clinical Enterobacterales using plasmid-wide CRISPRi screens
Conjugative plasmids are the main vehicle for the spread of antimicrobial resistance (AMR) genes in clinical bacteria. AMR plasmids allow bacteria to survive antibiotic treatments, but they also produce physiological alterations in their hosts that commonly translate into fitness costs. Despite the key role of plasmid-associated fitness effects in AMR evolution, their origin and molecular bases remain poorly understood. In this study, we introduce plasmid-wide CRISPR interference (CRISPRi) screens as a tool to dissect plasmid-associated fitness effects. We design and perform CRISPRi screens targeting the globally distributed carbapenem resistance plasmid pOXA-48 in 13 different multidrug resistant clinical Enterobacterales. Our results reveal that pOXA-48 gene-level effects are conserved across clinical strains, and expose the key role of the carbapenemase-encoding gene, blaOXA-48, as the main culprit for pOXA-48 fitness costs. Moreover, our results highlight the relevance of postsegregational killing systems in pOXA-48 vertical transmission, and uncover new genes implicated in pOXA-48 stability (pri, korC, DNDJGHEP_13 and 14 and H-NS). This study sheds new light on the biology and evolution of carbapenem resistant Enterobacterales and endorses CRISPRi screens as a powerful method for studying plasmid-mediated AMR., This work was supported by the European Research Council (ERC) under the European Union’s Horizon Europe research and innovation programme (ERC-2022-CoG Project 101086992 – PLAS-FIGHTER) and by
MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR (Project PCI2021- 122062- 2 A). A.C.V. was funded by an EMBO postdoctoral fellowship (ALTF 322-2022). We acknowledge
financial support from the Spanish State Research Agency, AEI/10.13039/501100011033, through the “Severo Ochoa” Programme for Centres of Excellence in R&D [SEV-2013-0347, SEV-2017-0712,
CEX2023-001386-S]., Peer reviewed
Project:
EC / H2020 101086992
,
MINECO / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021 - 2023 SEV-2013-0347
,
AEI CEX2023-001386-S
DOI: http://hdl.handle.net/10261/414109, https://api.elsevier.com/content/abstract/scopus_id/105013560877
HANDLE: http://hdl.handle.net/10261/414109, https://api.elsevier.com/content/abstract/scopus_id/105013560877